The Majority of the women suffering from any form of gestational trophoblastic disease can be successfully diagnosed and treated with preservation of their reproductive function. Managing molar pregnancies properly is crucial in diminishing the acute complications and identifying postmolar gestational trophoblastic neoplasia quickly. Individualizing treatment for women suffering from any form of gestational trophoblastic neoplasia is crucial. This individualization must be based on known risk factors, usage of less-toxic therapy for patients with low-risk diseases and aggressive multiagent therapy for those with high-risk diseases. Only the centers or consultants having experience in the complex multimodality treatment must manage Patients with high-risk gestational trophoblastic neoplasia.SOURCE- Soper JT. Gestational Trophoblastic Disease: Current Evaluation and Management [published correction appears in Obstet Gynecol. 2022 Jan 1;139(1):149]. Obstet
Gynecol. 2021;137(2):355-370. doi:10.1097/AOG.0000000000004240